#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	1340	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2458	159.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1627	1627	C	183	C	167	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2230	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4041	165.2	0	.	n	.	0	T695C	SNP	695	695	T	1287	1287	C	154	C,G	138,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2230	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4041	165.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1929	1929	A	209	A,G	188,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2230	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4041	165.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2563	2563	C	202	C	181	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2230	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4041	165.2	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3189	3189	T	177	T	158	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2230	23S	2890	2890	99.86	23S.l6.c4.ctg.1	4041	165.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2637	2637	A	231	A	206	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	226	folP	852	852	100.0	folP.l15.c4.ctg.1	2241	30.3	1	SNP	p	R228S	1	.	.	682	684	AGC	1352	1354	AGC	44;44;44	A;G;C	38;39;39	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	484	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3964	36.6	1	SNP	p	S91F	0	.	.	271	273	TCC	977	979	TCC	39;39;39	T;C;C	34;34;31	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	484	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3964	36.6	1	SNP	p	D95G	0	.	.	283	285	GAC	989	991	GAC	38;38;38	G;A;C	32;34;33	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	484	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3964	36.6	1	SNP	p	D95N	0	.	.	283	285	GAC	989	991	GAC	38;38;38	G;A;C	32;34;33	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	194	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1797	32.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	122	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1431	25.4	0	.	n	.	0	C187G	SNP	187	187	C	856	856	G	52	G	47	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	496	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3475	42.8	1	SNP	p	D86N	0	.	.	256	258	GAC	796	798	GAC	54;55;55	G;A,C;C	45;43,1;48	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	496	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3475	42.8	1	SNP	p	S87W	0	.	.	259	261	AGT	799	801	AGT	54;54;54	A,C;G;T	45,1;48;45	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	496	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3475	42.8	1	SNP	p	S87I	0	.	.	259	261	AGT	799	801	AGT	54;54;54	A,C;G;T	45,1;48;45	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	496	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3475	42.8	1	SNP	p	S87R	0	.	.	259	261	AGT	799	801	AGT	54;54;54	A,C;G;T	45,1;48;45	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	496	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3475	42.8	1	SNP	p	S88P	0	.	.	262	264	TCC	802	804	TCC	55;55;55	T;C;C,A	46;47;46,1	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	434	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3212	40.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1799	1801	GGC	53;53;51	G;G;C,G	48;49;44,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	356	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2805	38.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1524	1526	GCA	59;58;57	G;C;A,T,G	54;55;51,1,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	356	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2805	38.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1527	1529	ATC	56;56;57	A;T;C	53;53;53	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	356	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2805	38.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1539	1541	GTG	61;61;61	G;T;G	56;53;56	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	356	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2805	38.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1539	1541	GTG	61;61;61	G;T;G	56;53;56	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	356	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2805	38.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2043	2045	ACC	30;30;30	A;C;C	26;25;24	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	356	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2805	38.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2097	2099	GCG	26;25;25	G;C;G	22;20;18	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	356	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2805	38.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2097	2099	GCG	26;25;25	G;C;G	22;20;18	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	356	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2805	38.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2220	2222	GGC	35;35;35	G;G;C	32;32;31	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	356	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2805	38.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2229	2231	GGC	33;33;32	G;G;C	30;31;30	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	356	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2805	38.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2247	2249	CCG	32;33;32	C;C,A;G	30;28,1;27	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	498	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3453	43.1	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1803	1805	CTG	52;52;51	C;T;G	45;47;45	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	284	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2517	33.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	922	922	C	45	C	42	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	64	porB1a	984	188	91.15	porB1a.l15.c4.ctg.1	1550	12.1	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1387	1389	AAT	8;8;8	A;A;T	8;8;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	64	porB1a	984	188	91.15	porB1a.l15.c4.ctg.1	1550	12.1	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1390	1392	AAT	8;8;8	A;A;T	8;8;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	64	porB1a	984	188	91.15	porB1a.l15.c4.ctg.1	1550	12.1	0	.	p	.	0	A222V	NONSYN	664	666	GCT	1402	1404	GTT	8;8;8	G;T;T	8;7;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	64	porB1a	984	188	91.15	porB1a.l15.c4.ctg.1	1550	12.1	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1414	1416	GCA	7;7;7	G;C;A	7;6;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	64	porB1a	984	188	91.15	porB1a.l15.c4.ctg.1	1550	12.1	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1437	1439	GTA	7;7;7	G;T;A	7;6;7	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	64	porB1a	984	188	91.15	porB1a.l15.c4.ctg.1	1550	12.1	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1446	1446	A	7	A	7	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	396	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1814	63.5	0	.	p	.	0	G38E	NONSYN	112	114	GGA	575	577	GAA	68;68;67	G;A,C;A	60;62,1;59	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	396	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1814	63.5	0	.	p	.	0	S46G	NONSYN	136	138	AGC	599	601	GGC	63;63;64	G;G;C	57;57;58	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	396	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1814	63.5	0	.	p	.	0	E48G	NONSYN	142	144	GAA	605	607	GGA	67;67;67	G;G;A	60;63;61	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	396	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1814	63.5	0	.	p	.	0	T87A	NONSYN	259	261	ACT	722	724	GCT	68;67;67	G;C;T	61;61;60	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	396	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1814	63.5	0	.	p	.	0	T89S	NONSYN	265	267	ACC	728	730	AGC	64;62;63	A;G;C,A	57;58;56,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	396	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1814	63.5	0	.	p	.	0	.	MULTIPLE	358	359	AA	820	821	CG	64;64	C;G	60;61	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	396	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1814	63.5	0	.	p	.	0	.	MULTIPLE	361	362	GA	823	825	CAG	64;64;64	C;A;G	63;61;60	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	396	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1814	63.5	0	.	p	.	0	N122K	NONSYN	364	366	AAC	827	829	AAA	66;66;66	A;A;A,T	61;63;63,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	396	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1814	63.5	0	.	p	.	0	K143E	NONSYN	427	429	AAA	890	892	GAA	71;72;73	G;A;A	65;64;64	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	396	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1814	63.5	0	.	p	.	0	V151A	NONSYN	451	453	GTA	914	916	GCA	72;73;73	G;C;A	66;66;65	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	396	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1814	63.5	0	.	p	.	0	Q187R	NONSYN	559	561	CAA	1022	1024	CGA	75;75;75	C,A;G,A;A	66,1;66,1;67	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	396	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1814	63.5	0	.	p	.	0	A215T	NONSYN	643	645	GCT	1106	1108	ACT	82;83;82	A;C;T	74;71;70	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	396	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1814	63.5	0	.	p	.	0	Y216H	NONSYN	646	648	TAT	1109	1111	CAT	83;82;82	C;A,C;T	71;74,1;76	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	396	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1814	63.5	0	.	p	.	0	I218M	NONSYN	652	654	ATA	1115	1117	ATG	81;81;82	A;T;G	75;72;73	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	396	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1814	63.5	0	.	p	.	0	.	MULTIPLE	766	767	AC	1229	1231	GCA	75;75;74	G;C;A	68;67;67	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	396	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1814	63.5	0	.	p	.	0	W257R	NONSYN	769	771	TGG	1233	1235	CGG	74;74;74	C;G;G	69;70;66	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	396	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1814	63.5	0	.	p	.	0	S258fs	FSHIFT	772	772	A	1236	1236	A	74	A	68	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	396	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1814	63.5	1	SNP	p	G120K	1	.	.	358	360	AAG	820	822	CGG	64;64;64	C;G;G	60;61;63	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	396	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1814	63.5	1	SNP	p	A121D	1	.	.	361	363	GAC	823	826	CGC	64;64;64	C;G;C	63;60;62	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	396	porB1b	1047	1047	96.57	porB1b.l15.c17.ctg.1	1814	63.5	1	SNP	p	D121N	0	.	.	361	363	GAC	823	826	CGC	64;64;64	C;G;C	63;60;62	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	898	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5488	49.1	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2372	2374	AAT	58;58;58	A;A;T	51;50;49	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	184	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1495	37.0	1	SNP	p	V57M	1	.	.	169	171	ATG	713	715	ATG	68;68;69	A;T;G	56;59;61	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
